Genome-wide siRNA screen for mediators of NF-κB activation
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Although canonical NFκB is frequently critical for cell proliferation, survival, or differentiation, NFκB hyperactivation can cause malignant, inflammatory, or autoimmune disorders. Despite intensive study, mammalian NFκB pathway loss-of-function RNAi analyses have been limited to specific protein classes. We therefore undertook a human genome-wide siRNA screen for novel NFκB activation pathway components. Using an Epstein Barr virus latent membrane protein (LMP1) mutant, the transcriptional effects of which are canonical NFκB-dependent, we identified 155 proteins significantly and substantially important for NFκB activation in HEK293 cells. These proteins included many kinases, phosphatases, ubiquitin ligases, and deubiquinating enzymes not previously known to be important for NFκB activation. Relevance to other canonical NFκB pathways was extended by finding that 118 of the 155 LMP1 NF-κB activation pathway components were similarly important for IL-1β–, and 79 for TNFα–mediated NFκB activation in the same cells. MAP3K8, PIM3, and six other enzymes were uniquely relevant to LMP1-mediated NFκB activation. Most novel pathway components functioned upstream of IκB kinase complex (IKK) activation. Robust siRNA knockdown effects were confirmed for all mRNAs or proteins tested. Although multiple ZC3H-family proteins negatively regulate NFκB, ZC3H13 and ZC3H18 were activation pathway components. ZC3H13 was critical for LMP1, TNFα, and IL-1β NFκB-dependent transcription, but not for IKK activation, whereas ZC3H18 was critical for IKK activation. Down-modulators of LMP1 mediated NFκB activation were also identified. These experiments identify multiple targets to inhibit or stimulate LMP1-, IL-1β–, or TNFα–mediated canonical NFκB activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After demonstrating the ability to screen genetic knockouts for optical phenotypes, we sought to identify genes required for activation of NF-κB, a family of transcription factors (p50, p52, p65, RelB and c-Rel) that translocate to the nucleus in response to a host of stimuli (Gewurz et al., 2012; Hayden and Ghosh, 2012; Pahl, 1999).”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Gewurz et al., 2012
In the citing paper
“The hits in our screen included known pathway components annotated by KEGG (Kanehisa and Goto, 2000) for NF-κB activation by IL-1β signaling (5/5 genes), TNFα signaling (4/7 genes) and downstream components (5/7 genes), including cytokine-specific receptors, adaptor proteins, and factors that activate the shared regulator MAP3K7 (Figure 4D) (Gewurz et al., 2012).”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Gewurz et al., 2012
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Compagno, M., Lim, W. K., Grunn, A., Nandula, S. V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A., et al. (2009) · Nature · doi:10.1038/nature07968 · Cited by 1,038
A physical and functional map of the human TNF-α/NF-κB signal transduction pathway
Bouwmeester, T., Bauch, A., Ruffner, H., Angrand, P.-O., Bergamini, G., Croughton, K., Cruciat, C., Eberhard, D., Gagneur, J., Ghidelli, S., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1086 · Cited by 1,029
Involvement of linear polyubiquitylation of NEMO in NF-κB activation
Tokunaga, F., Sakata, S.-I., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K., Nakagawa, T., Kato, M., Murata, S., Yamaoka, S., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1821 · Cited by 942
Linear ubiquitination prevents inflammation and regulates immune signalling
Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H., Wong, W. W.-L., et al. (2011) · Nature · doi:10.1038/nature09816 · Cited by 940 · cited 1×
“K63 and linear Ub chains (10) recruit IKKγ and stimulate IKK activity.”
BackgroundThe IKK Complex, a Central Regulator of NF- B Activation
Israel, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000158 · Cited by 849
Haas, T. L., Emmerich, C. H., Gerlach, B., Schmukle, A. C., Cordier, S. M., Rieser, E., Feltham, R., Vince, J., Warnken, U., Wenger, T., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.013 · Cited by 775
Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation
Rahighi, S., Ikeda, F., Kawasaki, M., Akutsu, M., Suzuki, N., Kato, R., Kensche, T., Uejima, T., Bloor, S., Komander, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.007 · Cited by 744
Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay
Matsushita, K., Takeuchi, O., Standley, D. M., Kumagai, Y., Kawagoe, T., Miyake, T., Satoh, T., Kato, H., Tsujimura, T., Nakamura, H., et al. (2009) · Nature · doi:10.1038/nature07924 · Cited by 649
SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex
Tokunaga, F., Nakagawa, T., Nakahara, M., Saeki, Y., Taniguchi, M., Sakata, S.-I., Tanaka, K., Nakano, H., & Iwai, K. (2011) · Nature · doi:10.1038/nature09815 · Cited by 609 · cited 1×
“LUBAC is implicated in TNFα, IL-1β, LPS, and CD40-mediated canonical NFκB activation (6, 27), and siRNAs against individual subunits nearly met the LMP1 primary screen cutoff.”
BackgroundDirect activation of protein kinases by unanchored polyubiquitin chains
Xia, Z.-P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., & Chen, Z. J. (2009) · Nature · doi:10.1038/nature08247 · Cited by 575
Epstein–Barr virus in the pathogenesis of NPC
Raab-Traub, N. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x0200086x · Cited by 562
Variation in Transcription Factor Binding Among Humans
Kasowski, M., Grubert, F., Heffelfinger, C., Hariharan, M., Asabere, A., Waszak, S. M., Habegger, L., Rozowsky, J., Shi, M., Urban, A. E., et al. (2010) · Science · doi:10.1126/science.1183621 · Cited by 561
Matsuda, A., Suzuki, Y., Honda, G., Muramatsu, S., Matsuzaki, O., Nagano, Y., Doi, T., Shimotohno, K., Harada, T., Nishida, E., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206406 · Cited by 395
Powles, T., Robinson, D., Stebbing, J., Shamash, J., Nelson, M., Gazzard, B., Mandelia, S., Møller, H., & Bower, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6626 · Cited by 360
HSP27 Is a Ubiquitin-Binding Protein Involved in I-κBα Proteasomal Degradation
Parcellier, A., Schmitt, E., Gurbuxani, S., Seigneurin-Berny, D., Pance, A., Chantôme, A., Plenchette, S., Khochbin, S., Solary, E., & Garrido, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5790-5802.2003 · Cited by 325
Return to homeostasis: downregulation of NF-κB responses
Ruland, J. (2011) · Nature Immunology · doi:10.1038/ni.2055 · Cited by 322
Integrative analysis of the melanoma transcriptome
Berger, M. F., Levin, J. Z., Vijayendran, K., Sivachenko, A., Adiconis, X., Maguire, J., Johnson, L. A., Robinson, J., Verhaak, R. G., Sougnez, C., et al. (2010) · Genome Research · doi:10.1101/gr.103697.109 · Cited by 305 · cited 1×
“Somatic mutations of the LMP1 activation-pathway proteins TRAF2 and TAK1 have been identified in lymphoma (55), of ZC3H13 in gastric and colon carcinoma (56), and of ZC3H18 in melanoma (57).”
BackgroundSignaling to NF- B: Regulation by Ubiquitination
Wertz, I. E., & Dixit, V. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003350 · Cited by 300
Deubiquitinases in the regulation of NF-κB signaling
Harhaj, E. W., & Dixit, V. M. (2011) · Cell Research · doi:10.1038/cr.2010.166 · Cited by 261
Xu, M., Skaug, B., Zeng, W., & Chen, Z. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.002 · Cited by 246
The ubiquitin‐editing enzyme A20 requires RNF11 to downregulate NF‐κB signalling
Shembade, N., Parvatiyar, K., Harhaj, N. S., & Harhaj, E. W. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.285 · Cited by 211
Mukai, J., Hachiya, T., Shoji-Hoshino, S., Kimura, M. T., Nadano, D., Suvanto, P., Hanaoka, T., Li, Y., Irie, S., Greene, L. A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000140200 · Cited by 209
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients
Cesarman, E. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.03.003 · Cited by 185
Liang, J., Song, W., Tromp, G., Kolattukudy, P. E., & Fu, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002880 · Cited by 164
Epstein–Barr virus latent membrane protein 1 activation of NF-κB through IRAK1 and TRAF6
Luftig, M. A., Prinarakis, E., Yasui, T., Tsichritzis, T., Cahir-McFarland, E. D., Inoue, J., Nakano, H., Mak, T. W., Yeh, W., Li, X., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136756100 · Cited by 154
Self-citationLMP1 TRAFficking Activates Growth and Survival pathways
Soni, V., Cahir-McFarland, E. D., & Kieff, E. D. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_14 · Cited by 153
Self-citationMalignant pirates of the immune system
Rui, L., Schmitz, R., Ceribelli, M., & Staudt, L. M. (2011) · Nature Immunology · doi:10.1038/ni.2094 · Cited by 145
RNAi Screen in Mouse Astrocytes Identifies Phosphatases that Regulate NF-κB Signaling
Li, S., Wang, L., Berman, M. A., Zhang, Y., & Dorf, M. E. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.10.015 · Cited by 132
Vilar, M., Murillo‐Carretero, M., Mira, H., Magnusson, K., Besset, V., & Ibáñez, C. F. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601017 · Cited by 128
IKKα and IKKβ Each Function to Regulate NF-κB Activation in the TNF-Induced/Canonical Pathway
Adli, M., Merkhofer, E., Cogswell, P. C., & Baldwin, A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009428 · Cited by 123
TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1
Schultheiß, U., Püschner, S., Kremmer, E., Mak, T. W., Engelmann, H., Hammerschmidt, W., & Kieser, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.20.5678 · Cited by 121
Yeh, P. Y., Yeh, K.-H., Chuang, S.-E., Song, Y. C., & Cheng, A.-L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402362200 · Cited by 119
Naderi, A., Teschendorff, A. E., Beigel, J., Cariati, M., Ellis, I. O., Brenton, J. D., & Caldas, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4394 · Cited by 114
USP11 negatively regulates TNFα-induced NF-κB activation by targeting on IκBα
Sun, W., Tan, X., Shi, Y., Xu, G., Mao, R., Gu, X. F., Fan, Y., Yu, Y., Burlingame, S. M., Zhang, H., et al. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.10.008 · Cited by 110
Differential B‐lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1
Graham, J. P., Arcipowski, K. M., & Bishop, G. A. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00932.x · Cited by 106
Epstein-Barr Virus–Positive Diffuse Large B-Cell Lymphoma of the Elderly: What We Know So Far
Castillo, J. J., Beltrán, B., Miranda, R. N., Paydaş, S., Winer, E. S., & Butera, J. N. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0213 · Cited by 103
Transcriptomes of the B and T Lineages Compared by Multiplatform Microarray Profiling
Painter, M. W., Davis, S., Hardy, R. R., Mathis, D., Benoist, C., The Immunological Genome Project Consortium, Zhou, Y., Shinton, S., Hardy, R., Asinovski, N., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002695 · Cited by 102
RNA-destabilizing Factor Tristetraprolin Negatively Regulates NF-κB Signaling
Liang, J., Lei, T., Song, Y., Yanes, N., Qi, Y., & Fu, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024745 · Cited by 91
Lam, L. T., Davis, R. E., Ngo, V. N., Lenz, G., Wright, G., Xu, W., Zhao, H., Yu, X., Dang, L., & Staudt, L. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806491106 · Cited by 82
Eliopoulos, A. G., Davies, C. C., Blake, S. M. S., Murray, P. G., Najafipour, S., Tsichlis, P. N., & Young, L. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4567-4579.2002 · Cited by 61
Gewurz, B. E., Mar, J. C., Padi, M., Zhao, B., Shinners, N. P., Takasaki, K., Bedoya, E., Zou, J., Cahir-McFarland, E. D., Quackenbush, J. F., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00422-11 · Cited by 55
Self-citationKato, T., Gotoh, Y., Hoffmann, A., & Ono, Y. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01182.x · Cited by 54
Pim kinases are upregulated during Epstein–Barr virus infection and enhance EBNA2 activity
Rainio, E.-M., Ahlfors, H., Carter, K. L., Ruuska, M., Matikainen, S., Kieff, E., & Koskinen, P. J. (2005) · Virology · doi:10.1016/j.virol.2005.01.001 · Cited by 38
Self-citationHumtsoe, J. O., Liu, M., Malik, A. B., & Wary, K. K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00038-09 · Cited by 38
Sweet, T., Khalili, K., Sawaya, B. E., & Amini, S. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10701 · Cited by 33
The Trypanosoma brucei zinc finger protein ZC3H18 is involved in differentiation
Benz, C., Mulindwa, J., Ouna, B. A., & CLAYTON, C. E. (2011) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2011.02.007 · Cited by 33
Kondratiev, S., Duraisamy, S., Unitt, C., Green, M. R., Pinkus, G. S., Shipp, M. A., Kutok, J. L., Drapkin, R., & Rodig, S. J. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31822bd476 · Cited by 28
Cirhin up-regulates a canonical NF-κB element through strong interaction with Cirip/HIVEP1
Yu, B., Mitchell, G. A., & Richter, A. M. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.08.017 · Cited by 23
Kim, Y. R., Chung, N. G., Kang, M. R., Yoo, N. J., & Lee, S. H. (2010) · PubMed · Cited by 23
Boehm, D., Gewurz, B. E., Kieff, E. D., & Cahir-McFarland, E. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011752107 · Cited by 19
Self-citationMolecular Signatures Define New Rational Treatment Targets in Large B-Cell Lymphomas
Shipp, M. A. (2007) · Hematology · doi:10.1182/asheducation-2007.1.265 · Cited by 18
Research works printed but not linked: 1
- AB Rickinson, E Kieff, The role of Epstein-Barr virus infections in human malignancies. Fields Virology, eds DM Knipe, PM Howley (Lippincott Williams & Wilkins, Philadelphia), pp. 2511–2574 (2001).
Cited by
Epstein-Barr virus: Biology and clinical disease
Damania, B., Kenney, S. C., & Raab-Traub, N. (2022) · Cell · doi:10.1016/j.cell.2022.08.026 · Cited by 612
The IκB kinase complex in NF‐κB regulation and beyond
Hinz, M., & Scheidereit, C. (2014) · The EMBO Reports · doi:10.1002/embr.201337983 · Cited by 572
The RNA-binding protein repertoire of embryonic stem cells
Kwon, S. C., Yi, H., Eichelbaum, K., Föhr, S., Fischer, B., You, K. T., Castello, A., Krijgsveld, J., Hentze, M. W., & Kim, V. N. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2638 · Cited by 457
A library of TAL effector nucleases spanning the human genome
Kim, Y., Kweon, J., Kim, A., Chon, J. K., Yoo, J. Y., Kim, H. J., Kim, S., Lee, C., Jeong, E., Chung, E., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2517 · Cited by 370
Optical Pooled Screens in Human Cells
Feldman, D., Singh, A., Schmid-Burgk, J. L., Carlson, R. J., Mezger, A., Garrity, A. J., Zhang, F., & Blainey, P. C. (2019) · Cell · doi:10.1016/j.cell.2019.09.016 · Cited by 321
“An Optical Pooled Screen in Millions of Cells for Regulators of NF-kB Activation After demonstrating the ability to screen genetic knockouts for optical phenotypes, we sought to identify genes required for activation of NF-kB, a family of transcription factors (p50, p52, p65, RelB, and c-Rel) that translocate to the n…”
BackgroundInfluential
Metadata
- Authors
- Gewurz, B. E., Towfic, F., Mar, J. C., Shinners, N. P., Takasaki, K., Zhao, B., Cahir-McFarland, E. D., Quackenbush, J., Xavier, R. J., & Kieff, E.
- Affiliations
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Towfic, Fadi
- Mar, Jessica C.
- Shinners, Nicholas P.
- Kieff, Elliott
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-01-17
- Volume
- 109
- Issue
- 7
- Pages
- 2467-2472
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3289371
- OpenAlex
- W2110107948
- Cited by
- 108
- References
- 56
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 4 · 2023: 8 · 2022: 8 · 2021: 10 · 2020: 12 · 2019: 10 · 2018: 6 · 2017: 7 · 2016: 9 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 4
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Miami
- U.S. Public Health Service (R0183756, R01043351, HGS5P50HG004233)
- University of Texas MD Anderson Cancer Center
- National Human Genome Research Institute (P50HG004233)
- National Cancer Institute (K08CA140780, T32CA009031, R01CA047006, R01CA085180)
- National Institute of Allergy and Infectious Diseases (U54AI057159, R01AI062773)
- National Center for Research Resources (UL1RR025758)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NF-κB activation, canonical NF-κB signaling, genome-wide siRNA screen, IκB kinase complex, ZC3H13, MAP3K8, PIM3, ubiquitin ligase, IL-1β signaling, TNF signaling, transcriptional regulation
- MeSH terms
- Cell Line, Humans, Tumor Necrosis Factor-alpha, Genome, Human, NF-kappa B, RNA, Small Interfering, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.